Clinical trial
Weekly Paclitaxel Liposome Injection Plus Cisplatin in Preoperative Treatment of Breast Cancer
NCT02142010 is registered in ClinicalTrials.gov with Nanjing Luye Sike Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Weekly Paclitaxel Liposome Injection Plus Cisplatin in Preoperative Treatment of Breast Cancer
- Lead sponsor
- Nanjing Luye Sike Pharmaceutical Co., Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 31, 2014
- Completion date
- Not reported
- Enrollment
- 67 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer